Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins

Journal of Lipid Research

Volumn 44, Issue 12, 2003, Pages 2339-2348

  Kitchens, Richard L ^a   Thompson, Patricia A ^a   Munford, Robert S ^a   O'Keefe, Grant E ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Acute phase; Endotoxemia; Hypertriglyceridemia; Hypocholesterolemia; Sepsis

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; LIPID A; LIPOPOLYSACCHARIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DETOXIFICATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INFECTION; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN ISOLATION; SEPSIS;

ACUTE DISEASE; ACUTE-PHASE PROTEINS; CHOLESTEROL, VLDL; CRITICAL ILLNESS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INFLAMMATION; LIPOPOLYSACCHARIDES; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; PHOSPHOLIPIDS;

EID: 0346463257     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300228-JLR200     Document Type: Article

References (47)

1. Feingold, K. R., J. L. Funk, A. H. Moser, J. K. Shigenaga, J. H. Rapp, and C. Grunfeld. 1995. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect. Immun. 63: 2041-2046.
2. Munford, R. S., J. M. Andersen, and J. M. Dietschy. 1981. Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey. J. Clin. Invest. 68: 1503-1513.
3. Read, T. E., H. W. Harris, C. Grunfeld, K. R. Feingold, M. C. Calhoun, J. P. Kane, and J. H. Rapp. 1993. Chylomicrons enhance endotoxin excretion in bile. Infect. Immun. 61: 3496-3502.
4. Levine, D. M., T. S. Parker, T. M. Donnelly, A. Walsh, and A. L. Rubin. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA. 90: 12040-12044.
5. Pajkrt, D., J. E. Doran, F. Koster, P. G. Lerch, B. Arnet, T. van der Poll, J. W. ten Cate, and S. J. H. van Deventer. 1996. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J. Exp. Med. 184: 1601-1608.
6. Read, T. E., C. Grunfeld, Z. L. Kumwenda, M. C. Calhoun, J. P. Kane, K. R. Feingold, and J. H. Rapp. 1995. Triglyceride-rich lipoproteins prevent septic death in rats. J. Exp. Med. 182: 267-272.
7. Khovidhunkit, W., R. A. Memon, K. R. Feingold, and C. Grunfeld. 2000. Infection and inflammation-induced proatherogenic changes of lipoproteins. J. Infect. Dis. 181 (Suppl.): 462-472.
8. Fraunberger, P., S. Schaefer, K. Werdan, A. K. Walli, and D. Seidel. 1999. Reduction of circulating cholesterol and apolipoprotein levels during sepsis. Clin. Chem. Lab. Med. 37: 357-362.
9. Windler, E., U. Ewers-Grabow, J. Thiery, A. Walli, D. Seidel, and H. Greten. 1994. The prognostic value of hypocholesterolemia in hospitalized patients. Clin. Investig. 72: 939-943.
10. Gordon, B. R., T. S. Parker, D. M. Levine, S. D. Saal, J. C. L. Wang, B-J. Sloan, P. S. Barie, and A. L. Rubin. 2001. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit. Care Med. 29: 1563-1568.
11. Van Leeuwen, H. J., A. P. van Beek, G. M. Dallinga-Thie, J. A. G. Van Strijp, J. Verhoef, and K. P. M. Van Kessel. 2001. The role of high density lipoprotein in sepsis. Neth. J. Med. 59: 102-110.
12. Rauchhaus, M., A. J. S. Coats, and S. D. Anker. 2000. The endotoxin-lipoprotein hypothesis. Lancet. 356: 930-933.
13. Gallin, J. I., D. Kaye, and W. M. O'Leary. 1969. Serum lipids in infection. N. Engl. J. Med. 281: 1081-1086.
14. Feingold, K. R., and C. Grunfeld. 1994. Effects of endotoxin and cytokines on lipid metabolism. Curr. Opin. Lipidol. 5: 207-215.
15. Gotto, A. M., H. J. Pownall, and R. J. Havel. 1986. Introduction to the plasma lipoproteins. Methods Enzymol. 128: 3-41.
16. Parker, T. S., D. M. Levine, J. C. C. Chang, J. Laxer, C. C. Coffin, and A. L. Rubin. 1995. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect. Immun. 63: 253-258.
17. Wurfel, M. M., and S. D. Wright. 1997. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. J. Immunol. 158: 3925-3934.
18. Lerch, P. G., V. Förtsch, G. Hodler, and R. Bolli. 1996. Production and characterization of a reconstituted high density lipoprotein for therapeutic applications. Vox Sang. 71: 155-164.
19. Goldfarb, R. D., T. S. Parker, D. M. Levine, D. Glock, I. Akhter, A. Alkhudari, R.J. McCarthy, E. M. David, B. R. Gordon, S. D. Saal, A. L. Rubin, G. M. Trenholme, and J. E. Parrillo. 2002. Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284: R550-R557.
20. Cué, J. I., J. T. DiPiro, L. J. Brunner, J. E. Doran, M. E. Blankenship, A. R. Mansberger, and M. L. Hawkins. 1994. Reconstituted high density lipoprotein inhibits physiologic and tumor necrosis factor α responses to lipopolysaccharide in rabbits. Arch. Surg. 129: 193-197.
21. Eisenberg, S. 1984. High density lipoprotein metabolism. J. Lipid Res. 25: 1017-1058.
22. Vesy, C. J., R. L. Kitchens, G. Wolfbauer, J. J. Albers, and R. S. Munford. 1999. LPS binding protein and phospholipid transfer protein release lipopolysaccharides from gram negative bacterial membranes. Infect. Immun. 68: 2410-2417.
23. Kitchens, R. L., G. Wolfbauer, J. J. Albers, and R. S. Munford. 1999. Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J. Biol. Chem. 274: 34116-34122.
24. Levels, J. H. M., P. R. Abraham, A. Van den Ende, and S. J. H. van Deventer. 2001. Distribution and kinetics of lipoprotein-bound endotoxin. Infect. Immun. 69: 2821-2828.
25. Gordon, B. R., T. S. Parker, D. M. Devine, S. D. Saal, J. C. L. Wang, B-J. Sloan, P. S. Barie, and A. L. Rubin. 1996. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit. Care Med. 24: 584-589.
26. Harris, H. W., J. A. Johnson, and S. J. Wigmore. 2002. Endogenous lipoproteins impact the response to endotoxin in humans. Crit. Care Med. 30: 23-31.
27. Schwartz, Y. S., and M. I. Dushkin. 2002. Endotoxin-lipoprotein complex formation as a factor in atherogenesis: associations with hyperlipidemia and with lecithin: cholesterol acyltransferase activity. Biochemistry (Mosc.) 67: 747-752.
28. Munford, R. S., L. C. DeVeaux, J. E. Cronan, Jr., and P. D. Rick. 1992. Biosynthetic radiolabeling of bacterial lipopolysaccharide to high specific activity. J. Immunol. Methods. 148: 115-120.
29. Kitchens, R. L., P. A. Thompson, S. Viriyakosol, G. E. O'Keefe, and R. S. Munford. 2001. Plasma CD14 decreases monocyte responses to LPS by promoting the transfer of cell-bound LPS to plasma lipoproteins. J. Clin. Invest. 108: 485-493.
30. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20: 864-874.
31. Miller, J. P. 1990. Dyslipoproteinaemia of liver disease. Baillieres Clin. Endocrinol. Metab. 4: 807-832.
32. Cabana, V. G., J. N. Siegel, and S. M. Sabesin. 1989. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J. Lipid Res. 30: 39-49.
33. Mooser, V., M. M. Berger, L. Tappy, C. Cayeux, S. M. Marcovina, R. Darioli, P. Nicod, and R. Chioléro. 2000. Major reduction in plasma Lp(a) levels during sepsis and burns. Arterioscler. Thromb. Vasc. Biol. 20: 1137-1142.
34. He, X., F. Chen, M. M. McGovern, and E. H. Schuchman. 2002. A fluorescence-based, high-throughput sphingomyelin assay for the analysis of Niemann-Pick disease and other disorders of sphingomyelin metabolism. Anal. Biochem. 306: 115-123.
35. Barlage, S., D. Fröhlich, A. Böttcher, M. Jauhiainen, H. P. Müller, F. Noetzel, G. Rothe, C. Schütt, R. P. Linke, K. J. Lackner, C. Ehnholm, and G. Schmitz. 2001. ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J. Lipid Res. 42: 281-290.
36. Coombes, E. J., P. G. Shakespeare, and C. F. Batstone. 1980. Lipoprotein changes after burn injury in man. J. Trauma. 20: 971-975.
37. Wolfram, G., J. Eckart, and N. Zollner. 1980. Disturbances of lipoprotein and fatty acid metabolism in patients with heavy injuries. Klin. Wochenschr. 58: 1327-1337.
38. Sammalkorpi, K., V. Valtonen, Y. Kerttula, E. Nikkilä, and M-R. Taskinen. 1988. Changes in serum lipoprotein pattern induced by acute infection. Metabolism. 37: 859-865.
39. Samra, J. S., L. K. M. Summers, and K. N. Frayn. 1996. Sepsis and fat metabolism. Br. J. Surg. 83: 1186-1196.
40. Auerbach, B. J., and J. S, Parks. 1989. Lipoprotein abnormalities associated with lipopolysaccharide-induced lecithin: cholesterol acyltransferase and lipase deficiency. J. Biol. Chem. 264: 10264-10270.
41. Munford, R. S., C. L. Hall, and J. M. Dietschy. 1981. Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins. Infect. Immun. 34: 835-843.
42. Rensen, P. C. N., M. Van Oosten, E. Van de Bilt, M. Van Eck, J. Kuiper, and T. J. C. Van Berkel. 1997. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo. J. Clin. Invest. 99: 2438-2445.
43. Harris, H. W., S. E. Brady, and J. H. Rapp. 2002. Hepatic endosomal trafficking of lipoprotein-bound endotoxin in rats. J. Surg. Res. 106: 188-195.
44. Vreugdenhil, A. C. E., A. M. P. Snoek, C. Van't Veer, J. W. M. Greve, and W. A. Buurman. 2001. LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction. J. Clin. Invest. 107: 225-233.
45. Gijon, M. A., C. Perez, E. Mendez, and M. S. Crespo. 1995. Phospholipase A2 from plasma of patients with septic shock is associated with high-density lipoproteins and c3 anaphylatoxin: some implications for its functional role. Biochem. J. 306: 167-175.
46. Cai, T. Q., N. Thieblemont, B. Wong, R. Thieringer, B. P. Kennedy, and S. D. Wright. 1999. Enhancement of leukocyte response to lipopolysaccharide by secretory group IIA phospholipase A2. J. Leukoc. Biol. 65: 750-756.
47. Kasravi, F. B., W. J. Welch, C. A. Peters-Lideu, K. H. Weisgraber, and H. W. Harris. 2003. Induction of cytokine tolerance in rodent hepatocytes by chylomicron-bound LPS is low-density lipoprotein receptor dependent. Shock. 19: 157-162.